Arra Group, a Polish logistics company, key link in the European pharmaceutical supply chain, has entered into a strategic agreement with a global pharmaceutical operator– Walden Group.
Under the agreement, Walden Group acquires 40% of Arra Group shares. Thanks to the partnership Arra Group will benefit from global know-how to implement its growth strategy and will provide their customers with even greater geographical and infrastructural coverage. The alliance makes the companies the leading operator in life-sciencesEuropean distribution.
“By the strategic partnership agreement betweenour companies, Arra Group customers will enjoy all the benefits of top-class know-how in the pharmaceutical supply chain. It is a step forward to achieve the Arra Group vision of a global scope of services. The family nature of our companies are the foundation of effective cooperation aimed at supporting the development of our clients. The common values of both companies, Arra Group and Walden Group, put everyone – their customers, patients, and employees in the center of attention. Now, we can together implementpatient-oriented supply chains.”- comments Artur Ratajczak, CEO of Arra Group.
“Walden andArra Group have been close partners for a long time now. Arra Group impressive growth puts thecompany in a very high positionon the European market, connecting daily the whole European continent. This cooperation will provide to our life-science customers an access to a new GDP network based on700 compliant vehiclesfor their first mile supply chain. From an operational perspective, our business unit Transpharma International will coordinate this alliance. This partnership will provide a unique competitive solution with high quality standards for overland transport in Europe. ” – says Stéphane Baudry, CEO of Walden Group.